Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I don't know but TDA still has them as grey market. If the MJ business comes back, ADVT might get current. But, it is strange that on 28 Sept, this ticker comes back to life. As you know, 28 Sept was/is, yesterday the deadline for OTC stocks to get current.
Is it tradable ?
What is happening to ADVT today? BIG INCREASE in positive volume?
My error. TDA has ADVT ON THE GREY MARKET.
https://www.otcmarkets.com/stock/ADVT/profile
Show us your claim of behind the scenes current.
GOOD NEWS, ADVT IS NOT ON THIS TDA LIST.
I got this info from the UBQU board:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165755423
There is a TDA PDF file listing all the companies that are not up to date on their filings. Apparently, these companies will be put on the expert list. These companies has until the 28th of Sept 2021 to file in order to keep their standing as a pink stock.
AGAIN, ADVT IS NOT ON THE LIST. That means ADVT has been working, behind the scene, to stay up to date and thinking ADVT will rise again, one day, from the ashes.
I say take no action because the security will still be listed. Even if you want be able to liquidate the asset, there is a slight possibility the ticker might get bought by another company. Second, if you liquidate, you want get anything for your stock. Why bother.
Third, no action ensures there is an official record of your losses. If you took a lost by selling your stock, you will have to have a number of winning stocks to break even. You would also probably have to carry these losses over to the next year.
Fourth, transferring the stock to another brokerage would not be worth it. Cost is the main factor.
IMO,keep your stock.
I received the following message from TDAmeritrade today:
Quote:
On September 28, 2021, new amendments adopted by the U.S. Securities Exchange Commission (SEC) go into effect to enhance investor protection and improve issuer transparency. These amendments restrict the ability of market makers to publish quotations for those companies that have not made required current financial and company information available to regulators and investors.
Ahead of the regulatory enforcement date, we will only accept orders to liquidate positions (i.e. no new buy orders) starting August 13, 2021. After the amendment officially goes into effect on September 28, 2021, it may be more difficult to liquidate these securities. Quoting and market liquidity may also be very limited.
What this means for your account(s).
You are receiving this notification because you currently hold one or more of the impacted securities in your account. We're including the list below but be aware that it may not include all of your impacted securities. There is also a chance that the impacted companies could come into compliance with the regulatory requirements ahead of this date and be removed from the list. For a current list of all securities (which is subject to change), please visit www.tdameritrade.com/retail-en_us/resources/pdf/TDA101550.pdf.
You have multiple options to consider, such as:
Take no action. You are not required to sell these securities; however, starting August 13, 2021 we will restrict these securities to liquidation-only transactions. You may continue to hold them, but you may have difficulty selling them in the future and there is no guarantee as to what their future value will be.
Place trades to liquidate. You may place trades to liquidate these securities now. Due to the uncertainly, we cannot guarantee there will be sufficient liquidity to close your position(s) in the future.
Transfer your positions to another financial institution. Other U.S. financial institutions are also impacted by this amendment so you may have difficulty transferring them out of TD Ameritrade. If you are interested in transferring the assets, please submit any outgoing transfers requests to us. (These transactions may incur fees or commissions, depending on the asset type.)
Have Questions? Need Any Help?
We're here for you. Just reply to this message to write us, or call Client Services at 800-669-3900. We're available 24 hours a day, seven days a week.
Sincerely,
TD Ameritrade Client Service
ADVT: As of May 25, 2021, TD Ameritrade will restrict orders in Caveat Emptor designated OTC securities to liquidating trades only.
A Caveat Emptor security is a designation the OTC Markets Group places on a security after a determination was made surrounding the company that there may be potential risk to investors which include a questionable stock promotion, known investigation of fraudulent activity committed by the company or insiders, regulatory suspensions, or disruptive corporate actions, among other reasons.
The current list of Caveat Emptor restricted securities is below as of April 12, 2021 and is subject to change at any time.
Please visit www.otcmarkets.com for additional details and real time Caveat Emptor desiginations.
https://www.tdameritrade.com/retail-en_us/resources/pdf/cesecuritylist.pdf
007614100 ADVT Advantis Corporation
Good morning Bird, I went back to the web-site and looked at the article again. It now says Apr 6 but no year. I will go back and see where it was announced that he resigned and post it.
I sent a letter to Mr. Robert Broderick, Esq. yesterday to see if he would provide any information. I believe, like a number of other companies, ADVT has just stopped filing 10-Ks to the SEC. but are still in business. IMHO
Happy to see that you are still following ADVT. Have a great day. $ADVT
The CNN article you just posted dated 5 Apr 2021 indicated Cherry was still CEO.
I was doing some DD on ADVT and found a note that Darren Cherry resigned in August 2019. Does anyone know who the new CEO is?
Happy to see Darren Cherry is still listed as President, Chief Executive Officer & Secretary
Advantis Corp (Grey Market:ADVT)
SECTOR
Distribution Services
INDUSTRY
Medical Distributors
MARKET CAP
$483.2K
Company Description
Advantis Corp. engages in the provision of healthcare products and holistic pain management solutions. Its products is comprised of amster-can premium vapes, gino's roasters, hemperor's club premium vapes, rosin6 rosin press, n2pack and natural elements. The firm focuses on products that supply the medical cannabis, research, and pharmaceutical industries. The company was founded in 1992 and is headquartered in Newport Beach, CA.
Contact Information
Advantis Corp.
1048 Irvine Boulevard
Newport Beach California 92660
P:(949) 354-3585
Investor Relations:
www.advantiscorp.com
Top Executives
Darren Cherry President, Chief Executive Officer & Secretary
Thomas Elgin Chief Medical Officer
Chris Thue Chief Compliance Officer
Woo Kim Director & Director-Media Relations
Jay Ryu Technology Consultant
https://money.cnn.com/quote/profile/profile.html?symb=ADVT
Yes it is and I am glad to see it!
Lots of new amateurs traders losing money
Folks are buying up every OTCBB dead pos these days. Unreal.
Keep buying a dead stoke...grey market...hello lost money. Just put your money in the garbage can....same thing.
https://www.gzolehana.com/
Website take you here. Up 185% today
Is there anything to get this moving again.
Was a scam....dead dead....
Some volume here lately. Anybody but Bucky have any updates, developments on this?
Over a year later and it's still the same.
SEC Tightens Rule on OTC Issuer Information Disclosure
By Terry Flanagan -September 17, 2020
All it takes is a dollar (stock) and a dream.
That’s the mindset of many — possibly too many — retail investors who trade stocks over the counter. The OTC market is lightly regulated compared with NYSE and Nasdaq, and the securities are speculative. But there’s always the chance that dicey biotech, oil-exploration or cannabis firm that trades at $1 now will be $20 in a year.
The U.S. Securities and Exchange Commission on Wednesday took a step to make the wild west of the OTC market a little less wild by adopting an amended rule that bars broker-dealers from providing public price quotations on companies that have not provided current information about their business or their financials.
In a Wednesday afternoon telephone interview with Traders Magazine, Brett Redfearn, Director of the SEC’s Division of Trading and Markets, said that currently, about 3,000 of the 10,000 companies that trade OTC are in arrears on filing disclosure reports, to the extent that it would preclude broker-dealers from making public markets in their stocks.
“The bottom line is we’re trying to reduce the risk of fraud and manipulation and protect mainstream investors,” Redfearn said. “The idea is to say, “Get that financial information out there if you want to continue to be quoted in the same way.”
“We think this will allow retail investors to make better informed investment decisions, which will aid in reducing fraud in the over-the-counter market,” Redfearn said, citing ‘pump and dump’ schemes and other sketchy activity that tends to happen in OTC.
Redfearn noted that SEC already requires broker-dealers to review basic financial information of a company before initiating OTC price quotations, but there are loopholes such as the “piggyback rule,” which allows broker-dealers to sign off on information received from another broker, rather than directly from the issuer. The rule amendment disallows this by requiring that information come directly from the issuer, and be no more than one year old.
With the amended rule, the SEC has relaxed requirements for certain OTC securities issuers with actively traded securities whose information is more readily available, where there’s less concern about fraud. Also, “we recognize that not all issuers of quoted OTC securities do provide current publicly available financial information, so the commission going forward will consider requests for exemptive relief in certain circumstances,” Redfearn said. “Some of those circumstances could include limiting quoting to a market specifically for sophisticated or professional investors.”
In a release, the SEC said it “adopted amendments to Exchange Act Rule 15c2-11, an important component of the over-the-counter (“OTC”) market regulatory structure. The amendments are designed to modernize the rule, which was last substantively amended nearly thirty years ago, including to recognize advances in communications technologies. The amended rule enhances disclosure and investor protection in the OTC market by ensuring that broker-dealers, in their role as professional gatekeepers to this market, do not publish quotations for an issuer’s security when current issuer information is not publicly available, subject to certain exceptions.”
https://www.tradersmagazine.com/xtra/sec-tightens-rule-on-otc-issuer-information-disclosure/
machine was rented....the owner was kim woo you can find him on Facebook
You talk about buckyeye....insider i guess
Why does this turd still trade? Where are those crooks? Did they just sell the canning machine. We got scammed on this one. Where that big dummy that can’t spell. I think he was in on this scam.
Has new management tKen over this co yet? Any news?
This one done was a scam
zero. Well maybe it is not zero is positive? It's a write-off. May you profit elsewhere to use it wisely.
Anything positive here in terms of its pps? I own it much higher. Thanks.
Grey market...its dead...no more website...gone...
Nice to see the 20 and 50 day average are both at 0.0005 while the current pps is 0.0006. Will 0.0005 be the bottom? Holding for ADVT to restart their filling and reporting process. They had a good product, I hope they still do.
You are right...otc is full of s....
End of year action. Folks getting what they can. I'll just take my $0 later.
As far as scams go, this one did far less pumping and dumping than so many other POS OTC "companies" that should be suspended. These decisions on which to target appears arbitrary.
ADVT is still Grey Market...
.
Your very welcome...no I have not...
Thanks for the ADVT chart web address. Have you seen any news from ADVT?
Value getting close to what it's worth now.
Nope. Still Expert Market on otcmarkets and Grey on ET for me.
OTC has them listed back on pink sheets
Just a calculated risk...like any buy we make...
Hey, I hope you are right about something here. Good Luck.
Followers
|
255
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
48592
|
Created
|
12/18/07
|
Type
|
Free
|
Moderators |
iBox Page managed by: PotRelatedProducts
http://www.advantiscorp.com/
Financials
From the ADVT Website, "About": Advantis Corporation (ADVT) is focused on helping people take control of their health and pain management needs. By creating strategic partnerships with innovative companies in the nutraceutical and alternative health care industries, Advantis is uniquely positioned to provide the guidance and support to assist in delivering products and services that address the needs of these individuals. Acquiring ownership in developing companies allows Advantis to provide consultation to improve product lines, expand distribution channels, and heighten brand value. With the healthcare and pain management sectors forecasting staggering growth, Advantis identifies and partners with those companies that possess the potential to capitalize on this trend.
Acquisitions and product developments ensure that Advantis reaches sustainable revenue growth in the near-term as it prepares for future market opportunities. CEO, Christopher Swartz (Moderator: ADVT Site Outdated, CEO is D. Cherry) envisions the success of Advantis Corporation through strengthened partnerships, innovative product development, and sustained focus on revenue-producing strategies. With the help of a diverse and skilled management team, Swartz (Moderator: ADVT Site Outdated, CEO is D. Cherry)has navigated Advantis towards enhancing its footprint in the evolving legal cannabis business, holistic pain management, and healthcare industries. Expertise in the legal aspects of the medical cannabis industry allows Advantis to work within the framework of the law to target opportunities along the supply-chain of this untapped, explosive growth industry.
For more information about Advantis Corporation, https://advantiscorp.com/. Darren Cherry, CEO established in 2017 (Formally Chris Swartz)
From ADVT Website, "Investor Relations": Advantis Corporation (ADVT) develops products and works with developing companies to provide innovative healthcare products, holistic pain management solutions, and enhance the footprint in the evolving legal cannabis business. Advantis acquires ownership in developing companies that work within the nutraceutical and the alternative health care industries; consulting with these organizations to improve their product lines, expand their distribution channels through internal partnership agreements, and heighten brand value.
See actual production videos HERE (look for blue conveyor belt images)
https://www.instagram.com/advantiscorp/
Advantis Corporation Takes Major Step Toward OTC QB 06/03/19
Advantis Corp. Sets Meeting With N2 Pack at Las Vegas Cannabis Convention 04/01/19
Advantis Corp Signs Lease For Orange County Location 03/25/19
Advantis Corp. Meeting With N2Pack to Expand Partnership 03/12/19
Advantis Corp. Prepares for OTCBB 03/04/19
Advantis Corp Announces Imminent Lease Signing for OC Location, a Tripling of Monthly Amster-Can Orders with Existing Client 02/25/19
Advantis Corp. Moves Forward with Plans to Establish Los Angeles Presence, Partners with Statewide Distributor and Manufacturer 02/12/19
Advantis Corp. Acquiring New Canning Machine, Finalizing Sublingual Strip Agreement 02/04/19
Advantis Corp. Says Orders Doubled to Start the Year 01/28/19
Advantis Corp. Set for Major Expansion in 2019 01/22/19
Advantis Corp attended the MiBixCon in Las Vegas Last Week 11/26/18
Advantis Corp. Ups Q4 Guidance, Grows Relationships 11/13/18
Advantis Corp Forcasts 20% Quarterly Revenue Growth, Increased Margins 11/5/18
Advantis Corp. Looking to Team Up For MJBIZCON 10/30/18
Advantis Corp. Partners with NFL Great, Kyle Turley, Expands Product Lineup Three-Fold 10/22/18
Advantis Corp. Developing Own Brand of Edibles, CBD Product Lines 10/15/18
Advantis-Corp-Set-to-Debut-Proprietary-Sublingual-Delivery-System-Edible-Orders-Ramp-Up-Quickly 10/1/18
Advantis Corp Begins Packaging Edibles (9/24/18)
Advantis Corp Reports 30% Revenue Rise, Set to Increase Oregon Production by 50%
LINK - ADVANTIS CORPORATION (OTC PINK: ADVT) is set to report that revenue has increased over twenty percent over the first quarter (8/13/18)
LINK - Advantis Corp Sees Quarter Over Quarter Revenue Increases After New California Packaging Laws Take Effect
LINK - Advantis Corp. Expanding Into Two New Locations, As Demand Continues to Drive Further Production Capacity
LINK - Advantis Corp. Creates Synergy with Herb N Works 5/14/18
LINK - Advantis Corp. announced it is moving forward with plans to establish a pet division that will create and market a proprietary line of CBD-infused pet supplements and therapeutic pet edibles. 4/2/18
LINK - Advantis Corp. Signs Lease, Triples Production Capacity 3/12/18
LINK - Oregon Proves To Be Burgeoning Success for Advantis Corp. 03/05/2018
LINK - Advantis Corp. Unexpectedly Set To Triple California Amster-Can Revenue by End of 2nd Quarter 02/12/2018
LINK - Advantis Corp Expanding Into Colorado, California Nears Packaging Capacity With New Machine; Pre Orders for New Sizes Escalate Quickly 01/29/2018
LINK - California Cannabis Legalization for Adult Use Leads to Record Month for Advantis Corp. 01/16/2018
LINK - Advantis Corp. Partners with Players Network’s Green Leaf Farms and Expands Its Product Line into Nevada 01/10/2018
LINK - Advantis Corp. Expects Quarterly Revenue Records Throughout 2018 12/18/2017
LINK - Advantis Corp. Hits Home Run with Oregon Deal 11/14/2017
LINK - Advantis Corp. Negotiates Agreement with Las Vegas Proprietor, New Amster-Can Equipment Ramping Up to Full Production 10/02/2017
LINK - Advantis Corp. Established Presence in Oregon Leads to New Contract 09/24/2017
LINK - Industry Leader, Darren Cherry, Leads Advantis Corp. Into the Future 09/19/2017
LINK - Advantis Corp. Setting Up Multi-State Amster-Can Canning Solutions 08/21/2017
ADVANTIS CORPORATION PRODUCTS AND HOLDINGS (Source-1 Source-2)
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |